Beta-Agonists, Inhaled Long Acting

← Back to Class List

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

Generic Name Brand Name Form PDL
Current Drug Use Criteria New Drug Evaluation
salmeterol xinafoate SEREVENT DISKUS BLST W/DEV Y    
arformoterol tartrate ARFORMOTEROL TARTRATE VIAL-NEB N PA Document  
arformoterol tartrate BROVANA VIAL-NEB N PA Document  
formoterol fumarate PERFOROMIST VIAL-NEB N PA Document  
formoterol fumarate FORMOTEROL FUMARATE VIAL-NEB N PA Document  
olodaterol HCl STRIVERDI RESPIMAT MIST INHAL N PA Document Jan 29, 2015